Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Retz

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
The Journal of Urology|October 12, 2000
A hypoechoic lesion found on testicular ultrasound after testicular piercingJ Lehmann, C Jancke, M Retz, et al.
Der Urologe. Ausg. A|November 6, 2009
[Symposium of the German Bladder Cancer Association]M Retz, R Nawroth, P Olbert, et al.
Cancer Research|December 29, 1998
Differential mucin MUC7 gene expression in invasive bladder carcinoma in contrast to uniform MUC1 and MUC2 gene expression in both normal urothelium and bladder carcinomaM Retz, J Lehmann, C Röder, et al.
Der Urologe. Ausg. A|January 20, 2011
[Bladder cancer update: what was new at the 2010 annual congress of the German Association of Urology in Düsseldorf?]R Nawroth, A Hartmann, P J Olbert, et al.
British Journal of Cancer|October 29, 2014
Mutant PIK3CA controls DUSP1-dependent ERK 1/2 activity to confer response to AKT target therapyA Sathe, F Guerth, M V Cronauer, et al.
European Urology|July 21, 2001
Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patientsM Retz, J Lehmann, C Röder, et al.
Journal of Medicinal Chemistry|July 6, 2000
Fenchylamine sulfonamide inhibitors of amyloid beta peptide production by the gamma-secretase proteolytic pathway: potential small-molecule therapeutic agents for the treatment of Alzheimer's diseaseG M Rishton, D M Retz, P A Tempest, et al.
Bladder Cancer (Amsterdam, Netherlands)|December 31, 2016
The Role of PD-L1 Expression and Intratumoral Lymphocytes in Response to Perioperative Chemotherapy for Urothelial CarcinomaF Erlmeier, A K Seitz, G Hatzichristodoulou, et al.
Cancer|August 30, 2000
Long term follow-up of combined radiochemotherapy for locally advanced bladder carcinomaM Retz, J Lehmann, C Trocha, et al.
The Journal of Urology|February 15, 2001
High frequency microsatellite instability in mucinous adenocarcinoma of the prostateB Wullich, S Verelst, V Rohde, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Urology|October 12, 2000
A hypoechoic lesion found on testicular ultrasound after testicular piercingJ Lehmann, C Jancke, M Retz, et al.
Der Urologe. Ausg. A|November 6, 2009
[Symposium of the German Bladder Cancer Association]M Retz, R Nawroth, P Olbert, et al.
Cancer Research|December 29, 1998
Differential mucin MUC7 gene expression in invasive bladder carcinoma in contrast to uniform MUC1 and MUC2 gene expression in both normal urothelium and bladder carcinomaM Retz, J Lehmann, C Röder, et al.
Der Urologe. Ausg. A|January 20, 2011
[Bladder cancer update: what was new at the 2010 annual congress of the German Association of Urology in Düsseldorf?]R Nawroth, A Hartmann, P J Olbert, et al.
British Journal of Cancer|October 29, 2014
Mutant PIK3CA controls DUSP1-dependent ERK 1/2 activity to confer response to AKT target therapyA Sathe, F Guerth, M V Cronauer, et al.
European Urology|July 21, 2001
Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patientsM Retz, J Lehmann, C Röder, et al.
Journal of Medicinal Chemistry|July 6, 2000
Fenchylamine sulfonamide inhibitors of amyloid beta peptide production by the gamma-secretase proteolytic pathway: potential small-molecule therapeutic agents for the treatment of Alzheimer's diseaseG M Rishton, D M Retz, P A Tempest, et al.
Bladder Cancer (Amsterdam, Netherlands)|December 31, 2016
The Role of PD-L1 Expression and Intratumoral Lymphocytes in Response to Perioperative Chemotherapy for Urothelial CarcinomaF Erlmeier, A K Seitz, G Hatzichristodoulou, et al.
Cancer|August 30, 2000
Long term follow-up of combined radiochemotherapy for locally advanced bladder carcinomaM Retz, J Lehmann, C Trocha, et al.
The Journal of Urology|February 15, 2001
High frequency microsatellite instability in mucinous adenocarcinoma of the prostateB Wullich, S Verelst, V Rohde, et al.
Pageof 9